Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Cancer. 2018 Jan 9;124(7):1507–1515. doi: 10.1002/cncr.31227

TABLE 1.

Characteristics of Hematopoietic Cell Transplantation (HCT) Survivors With and Without Prior Ischemic Heart Disease at Baseline Survey

Characteristics, n (%) No prior disease
N=2,198
With prior disease
N=162
P-value
Female 1,061 (48) 42 (26) <.001
White, non-Hispanic 1,959 (89) 145 (90) .88
Median age at HCT (range), years 43.6 (0.4–78.8) 48.9 (10.0–78.9) <.001
Median age at cohort entry (range), years 55.5 (20.2–83.3) 62.4 (22.0–83.0) <.001
Original disease .25
  Leukemia / myelodysplastic syndrome 1,265 (58) 102 (63)
  Lymphoma 481 (22) 26 (16)
  Multiple myeloma 234 (11) 19 (12)
  Other cancer 60 (3) 1 (1)
  Non-malignant condition 158 (7) 14 (9)
Donor type .42
  Autologous 635 (29) 42 (26)
  Allogeneic 1,563 (71) 120 (74)
History of chronic graft vs. host disease 967 (62)* 95 (79)* <.001
Body mass index categories, kg/m2 .046
  <18.5 66 (3) 2 (1)
  18.5–24.9 945 (44) 55 (34)
  25–29.9 744 (34) 67 (42)
  ≥30 411 (19) 36 (23)
Hypertension 568 (26) 90 (56) <.001
Dyslipidemia 673 (31) 126 (78) <.001
Diabetes 281 (13) 55 (34) <.001
Current smoker 157 (8) 17 (10) .18
Fruit/vegetable intake
  No. servings/day, median (interquartile range) 3.4 (2.1–5.2) 3.2 (2.0–4.6) .23
  ≥5 servings/day 509 (28) 29 (22) .11
Physical activity, minutes/week .023
  <90 611 (38) 59 (48)
  90–239 511 (31) 40 (32)
  ≥240 504 (31) 25 (20)
  Met national activity recommendations 1,079 (66) 67 (54) .005
Died during follow-up period 277 (13) 39 (24) <.001
*

Among allogeneic recipients.

In terms of vigorous physical activity; comparable time spent doing moderate activity was divided by two.

150 minutes of moderate activity per week or 75 minutes of vigorous activity per week, or equivalent mixture of both